Phycocyanin is a type of pigment found in blue-green algae. It is used as a food additive, and it has been studied for its potential health benefits. Phycocyanin can be extracted from the cells of blue-green algae, or it can be synthesized in laboratories. The global pharmaceutical grade phycocyanin market was valued at USD 1.2 billion in 2018 and is projected to reach USD 2.5 billion by 2030, growing at a CAGR of 8% during the forecast period from 2021 to 2030.
The global pharmaceutical grade phycocyanin market has been segmented on the basis of type into C Phycocyanin and R Phycocyanin; on the basis of application into health care products and medicine; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The North American region dominated this market with over 40% share in 2018 owing to high demand for phytochemicals such as phycoerythrin which are used as food additives or natural colorants for foods such as ice cream or yogurt due to their antioxidant properties that help protect against free radicals that cause oxidative stress which may lead to cancer or other diseases such as Alzheimer's disease.
Some Of The Growth Factors Of This Market:
- The global population is aging and the number of people with chronic diseases is increasing.
- Increasing awareness about health benefits of phycocyanin in food, beverages, supplements, cosmetics and pharmaceuticals.
- Growing demand for natural products.
Industry Growth Insights published a new data on “Pharmaceutical Grade Phycocyanin Market”. The research report is titled “Pharmaceutical Grade Phycocyanin Market research by Types (C Phycocyanin, R Phycocyanin), By Applications (Health Care Products, Medicine, Other), By Players/Companies DIC Corporation, Japan Algae, Parry Nutraceuticals, Ozone Naturals, EcoFuel Laboratories, Nan Pao International Biotech, King Dnarmsa Spirulina, Zhejiang Binmei Biotechnology, Wuli Lvqi”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Phycocyanin Market Research Report
By Type
C Phycocyanin, R Phycocyanin
By Application
Health Care Products, Medicine, Other
By Companies
DIC Corporation, Japan Algae, Parry Nutraceuticals, Ozone Naturals, EcoFuel Laboratories, Nan Pao International Biotech, King Dnarmsa Spirulina, Zhejiang Binmei Biotechnology, Wuli Lvqi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Phycocyanin Market Report Segments:
The global Pharmaceutical Grade Phycocyanin market is segmented on the basis of:
Types
C Phycocyanin, R Phycocyanin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Health Care Products, Medicine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DIC Corporation
- Japan Algae
- Parry Nutraceuticals
- Ozone Naturals
- EcoFuel Laboratories
- Nan Pao International Biotech
- King Dnarmsa Spirulina
- Zhejiang Binmei Biotechnology
- Wuli Lvqi
Highlights of The Pharmaceutical Grade Phycocyanin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- C Phycocyanin
- R Phycocyanin
- By Application:
- Health Care Products
- Medicine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Phycocyanin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade phycocyanin is a purified form of the blue pigment found in marine algae. It is used as a food additive and cosmetic ingredient.
Some of the key players operating in the pharmaceutical grade phycocyanin market are DIC Corporation, Japan Algae, Parry Nutraceuticals, Ozone Naturals, EcoFuel Laboratories, Nan Pao International Biotech, King Dnarmsa Spirulina, Zhejiang Binmei Biotechnology, Wuli Lvqi.
The pharmaceutical grade phycocyanin market is expected to register a CAGR of 8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Grade Phycocyanin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Grade Phycocyanin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Grade Phycocyanin Market - Supply Chain
4.5. Global Pharmaceutical Grade Phycocyanin Market Forecast
4.5.1. Pharmaceutical Grade Phycocyanin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Grade Phycocyanin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Grade Phycocyanin Market Absolute $ Opportunity
5. Global Pharmaceutical Grade Phycocyanin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
5.3.1. C Phycocyanin
5.3.2. R Phycocyanin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Grade Phycocyanin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
6.3.1. Health Care Products
6.3.2. Medicine
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Grade Phycocyanin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Grade Phycocyanin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Grade Phycocyanin Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Grade Phycocyanin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
9.4.1. Health Care Products
9.4.2. Medicine
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
9.7.1. C Phycocyanin
9.7.2. R Phycocyanin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Grade Phycocyanin Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Grade Phycocyanin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
10.4.1. Health Care Products
10.4.2. Medicine
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
10.7.1. C Phycocyanin
10.7.2. R Phycocyanin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Grade Phycocyanin Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Grade Phycocyanin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
11.4.1. Health Care Products
11.4.2. Medicine
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
11.7.1. C Phycocyanin
11.7.2. R Phycocyanin
11.8. Basis Point Share (BPS) Analysi by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Grade Phycocyanin Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Grade Phycocyanin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
12.4.1. Health Care Products
12.4.2. Medicine
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
12.7.1. C Phycocyanin
12.7.2. R Phycocyanin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Grade Phycocyanin Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Grade Phycocyanin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Application
13.4.1. Health Care Products
13.4.2. Medicine
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Grade Phycocyanin Market Size and Volume Forecast by Type
13.7.1. C Phycocyanin
13.7.2. R Phycocyanin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Grade Phycocyanin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Grade Phycocyanin Market: Market Share Analysis
14.2. Pharmaceutical Grade Phycocyanin Distributors and Customers
14.3. Pharmaceutical Grade Phycocyanin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. DIC Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Japan Algae
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Parry Nutraceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ozone Naturals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. EcoFuel Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nan Pao International Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. King Dnarmsa Spirulina
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhejiang Binmei Biotechnology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Wuli Lvqi
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
